Board of Fermenta Biotech approves closure of Fermenta Biotech (UK)

At meeting held on 05 November 2026

The board of Fermenta Biotech at its meeting held on 05 November 2026 has given its approval to close the Company's wholly owned subsidiary viz. Fermenta Biotech (UK) (FBL UK) by way of feasible permissible modes as per the provisions of the United Kingdom Law. FBL UK is not a material subsidiary of the Company.

FBL UK was acquired by the Company on 10 September 2002. However, owing to various reasons including exit of the United Kingdom from the European Union and the Company having an operational wholly-owned subsidiary in Germany viz. Fermenta Biotech GmbH to cater to the European market, there have been no operations in FBL UK for several years. As per the financials for F.Y. 2025-26, FBL UK had no turnover and had a loss of ? 1,260. Its Net assets were ? 30,231 mostly comprising cash at bank. The decision to close FBL UK is mainly in order to have better corporate structure reorganization and reduce compliance costs.